News and Information
Archives
December 12, 2006, Press Release
Phylonix Awarded National Science Foundation Phase II SBIR to Screen Industrial Chemicals for Effects on Developmental Toxicity in Zebrafish
August 8, 2006, Press Release
Zebrafish Show Advantages in Assessing Human Cancer Cell-Induced Angiogenesis In Vivo
May 10, 2006, Press Release
Phylonix Issued Broad U.S. Patent for Screening Angiogenic Compounds using Zebrafish
June 2, 2004, Press Release
NIH Awards Phylonix Phase II SBIR to Develop Zebrafish Apoptosis Drug Screening Assays
March 30, 2004, Press Release
Phylonix Granted U.S. Patent for High Throughput Drug Screening Using Zebrafish
December 18, 2007, Marketwire
Phylonix Granted Broad European Patent for Transplanting Human Cells Into Zebrafish
October 2, 2007, Press Release
NIH Awards Phylonix Phase II SBIR to Develop Zebrafish Models for Eye Diseases
April 12, 2007, Press Release
